Filing Details

Accession Number:
0001209191-20-035174
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-08 21:08:34
Reporting Period:
2020-06-04
Accepted Time:
2020-06-08 21:08:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1545439 Bullaro Lauren Riker C/O Pacira Biosciences, Inc.
5 Sylvan Way, Suite 300
Parsippany NJ 07054
Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-06-04 879 $46.33 9,585 No 4 S Direct
Common Stock Disposition 2020-06-05 1,752 $48.37 7,833 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.37 to $48.45, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.